A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Clinical trial NCT00866281 · TERMINATED

Trial details

NCT number: NCT00866281
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia

Start date: 2009-09-01
Primary completion: 2014-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.